HIGHLIGHTS
- who: O papel do dolutegravir and colleagues from the Centro de Ensino Superior de Universidade Federal de Juiz de have published the Article: HU Revista, Juiz de Fora, v. 44, n. 3, p. 379-385, jul./set, in the Journal: (JOURNAL)
- what: In this context this study is bibliographical review study conducted from January to June 2018 of scientific papers on scientific Articles dealing with exclusive aspects of in therapy compared to other therapeutic regimens.
SUMMARY
RESULTADOS O primeiro inibidor da integrase (INI) foi aprovado pela Food Drug Administration (FDA) em . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.